Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C8orf44-SGK3 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | INO80E | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | GLYATL3 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | PDCL3 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | CARD14 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | GORASP1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | HNRNPL | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | BTNL2 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | NT5M | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | OR4K14 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |